secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0001193125-25-245871
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Disc Medicine prices upsized $250M offering; net proceeds ~$210.9M to fund bitopertin and extend cash runway into 2029
--------------------------------------------------------------------------------

- Net proceeds to Disc Medicine expected ~$210.9M; funds will support bitopertin commercialization for EPP/XLP, R&D, and general corporate purposes.
- Selling stockholder AI DMI LLC sold 297,619 shares at $84.00; underwriters exercised option to purchase additional 446,428 shares from AI DMI.
- Company expects cash, equivalents, and marketable securities plus offering net proceeds to fund operations into 2029, excluding potential bitopertin revenue.
- Pre-funded warrants have $0.0001 exercise price, immediate exercisability, and 24.99% ownership limit; not listed on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000119312525245871/0001193125-25-245871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000119312525245871/d49689d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-245871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer